Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Specific Peptide Vaccine Against IDH1(R132H) Glioma.

Neuroscience bulletin - 1 Feb 2022

Huang Yuqian, Wang Yongjie, Huang Zhihui

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioma
Share to Isocitrate Dehydrogenase
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Vaccines, Subunit

Source

Open in PubMed Open full text

Identifiers

PMID: 34739683
DOI: 10.1007/s12264-021-00791-9
PMCID: PMC8821749

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Specific Peptide Vaccine Against IDH1(R132H) Glioma.PMID 34739683Read ↗

A vaccine targeting mutant IDH1 in newly diagnosed glioma.Semantic proximity Read ↗

A vaccine targeting mutant IDH1 induces antitumour immunity.Semantic proximity Read ↗

Vaccination for IDH-mutant tumors: A novel therapeutic approach applied to glioma.Semantic proximity Read ↗

The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant GliomasSemantic proximity Read ↗

In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccination.Semantic proximity Read ↗

A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma.Semantic proximity Read ↗

Isocitrate dehydrogenase mutations in gliomas: A review of current understanding and trialsSemantic proximity Read ↗

IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.Semantic proximity Read ↗

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomasSemantic proximity Read ↗

Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma.Semantic proximity Read ↗

Mutation-specific T cells for immunotherapy of gliomas.Semantic proximity Read ↗

Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.